Immune protection effect of exosomes against attack of L1210 tumor cells

被引:38
作者
Bu, Ning
Li, Qi-ng Li
Feng, Qi
Sun, Bing-Zhong
机构
[1] Xijing Hosp, Dept Hematol, Xian, Peoples R China
[2] Xijing Hosp, Dept Gynecol & Obstet, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
exosome; vaccine; tumor immunity; leukemia;
D O I
10.1080/10428190500376191
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the anti-tumor immunity of L1210 cell-secreted exosomes. Exosomes were purified by ultrafiltration centrifugation and sucrose gradient ultracentrifugation. Expression of H-2D and interstitial cell adhesion molecule (ICAM)-1 was investigated by solid-phase immuno-electron microscopy and expression of Hsp70 was investigated by western blotting. DBA/2 mice were immunized with a given dose of exosomes (2.5 or 5 mu g). Transmission electron microscopy revealed that L1210-derived exosomes were membrane vesicles. They were labeled by colloidal gold H-2D and ICAM-1. Western blot analysis demonstrated the presence of Hsp70 antigens in L1210 exosomes. Exosome immunization partly inhibited the growth of implanted tumor in mice. There was a significant difference between exosome groups and the control group (P<0.05). In conclusion, exosomes can be considered as a candidate therapeutic vaccine for leukemia.
引用
收藏
页码:913 / 918
页数:6
相关论文
共 30 条
  • [1] Exosomes from plasmacytoma cells as a tumor vaccine
    Altieri, SL
    Khan, ANH
    Tomasi, TB
    [J]. JOURNAL OF IMMUNOTHERAPY, 2004, 27 (04) : 282 - 288
  • [2] Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
    André, F
    Chaput, N
    Schartz, NEC
    Flament, C
    Aubert, N
    Bernard, J
    Lemonnier, F
    Raposo, G
    Escudier, B
    Hsu, DH
    Tursz, T
    Amigorena, S
    Angevin, E
    Zitvogel, L
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (04) : 2126 - 2136
  • [3] Malignant effusions and immunogenic tumour-derived exosomes
    Andre, F
    Schartz, NEC
    Movassagh, M
    Flament, C
    Pautier, P
    Morice, P
    Pomel, C
    Lhomme, C
    Escudier, B
    Le Chevalier, T
    Tursz, T
    Amigorena, S
    Raposo, G
    Angevin, E
    Zitvogel, L
    [J]. LANCET, 2002, 360 (9329) : 295 - 305
  • [4] Arnold-Schild D, 1999, J IMMUNOL, V162, P3757
  • [5] Detection of human polyomaviruses in urine from bone marrow transplant patients:: Comparison of electron microscopy with PCR
    Biel, SS
    Nitsche, A
    Kurth, A
    Siegert, W
    Özel, M
    Gelderblom, HR
    [J]. CLINICAL CHEMISTRY, 2004, 50 (02) : 306 - 312
  • [6] TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/ζ complex
    Blanchard, N
    Lankar, D
    Faure, F
    Regnault, A
    Dumont, C
    Raposo, G
    Hivroz, C
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3235 - 3241
  • [7] BU N, 2005, J 4 MIL MED U, V26, P241
  • [8] Exosome-based immunotherapy
    Chaput, N
    Taïeb, J
    Schartz, NEC
    André, F
    Angevin, E
    Zitvogel, L
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) : 234 - 239
  • [9] Exosomes as potent cell-free peptide-based vaccine.: II.: Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection
    Chaput, N
    Schartz, NEC
    André, F
    Taïeb, J
    Novault, S
    Bonnaventure, P
    Aubert, N
    Bernard, J
    Lemonnier, F
    Merad, M
    Adema, G
    Adams, M
    Ferrantini, M
    Carpentier, AF
    Escudier, B
    Tursz, T
    Angevin, E
    Zitvogel, L
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (04) : 2137 - 2146
  • [10] CHRISTIAN D, 2002, P AN M AM SOC CLIN, V21, P1802